Topical anesthesia in addition to intravaginal tablet misoprostol versus Paracervical block a form of anesthesia procedure for women undergoing Dilatation Curettage A Randomized controlled trail

Topial anesthesia in addition to intravaginal misoprostol versus Paracervical block for women undergoing Dilatation Curettage- A Randomized controlled trail

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021465

Enrollment

128

Registered

2019-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: Topical anesthesia in addition to intravaginal misoprostol versus Paracervical block for women undergoing Dilatation and curettage-A randomized controlled trail: comparing the VAS score

Eligibility

Inclusion criteria

Inclusion criteria: women undergoing Dilataion and Curettagein gynecological department

Exclusion criteria

Exclusion criteria: 1.cardiac disease 2.seziure disorder 3.bleeding disorder and patient on anticoagulant 4.asthma disease 5.patient on chronic glucocorticoid therapy 6.pregnancy

Design outcomes

Primary

Measure	Time frame
To compare the VAS score between topical anesthesia with intravaginal misoprostol and paracervical block for women undergoing dilataion and curettageTimepoint: VAS score was done during diatation and curettage	—

Secondary

Measure	Time frame
1.To compare the ambulation time and discharge time of the patients between the two techniques 2.To evaluate complications if any associated with misoprostol, lignocaine and paracervical block used for D&CTimepoint: 1.At baseline 2.During procedure 3.30 minutes after D&C;To compare the ambulation time and discharge time of the patients between the two techniques To evaluate complications if any associated with misoprostol lignocaine and paracervical block used for dilatation and curettageTimepoint: From starting of study to thirty minutes after dilataion and curettage	—

Measure

Time frame

1.To compare the ambulation time and discharge time of the patients between the two techniques 2.To evaluate complications if any associated with misoprostol, lignocaine and paracervical block used for D&CTimepoint: 1.At baseline 2.During procedure 3.30 minutes after D&C;To compare the ambulation time and discharge time of the patients between the two techniques To evaluate complications if any associated with misoprostol lignocaine and paracervical block used for dilatation and curettageTimepoint: From starting of study to thirty minutes after dilataion and curettage

—

Countries

India

Contacts

Public ContactDr KARTHICK G

JIPMER

p_kundra@hotmail.com9367602030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026